Carl R Merril

Inventor

Add to Portfolio

Stats

Details

Work History

Patent OwnerApplications FiledYear
THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
1
2
1
1
1
1
5
1
1
4
2
3
5
1
1
1982
1984
1986
1987
1988
1991
1992
1993
1994
1995
1996
2001
2003
2004
2005
Panacea Pharmaceuticals, Inc.
3
1
1
2001
2013
2016
Exponential Biotherapies, Inc.
2
2
2
1
1995
1996
2001
2003
PANACEA PHARMACEUTICALS
3
2013
VIRXSYS CORPORATION
2
1
2003
2008
Monoclonetics International, Inc.
1
1
1
1
1987
1992
1994
1995
THE UNITED STATES OF AMERICA
1
1992

Inventor Addresses

AddressDuration
2 Winder Ct., Rockville, MD 20850Jul 04, 95 - Jul 04, 95
Bethesda, MDOct 17, 02 - Jul 15, 08
Bethesda, MD, USJul 08, 04 - Aug 06, 20
ROCKVILLE, MDFeb 06, 03 - Feb 06, 03
Rockville, MDSep 20, 83 - Feb 19, 08
Rockville, MD, USNov 20, 03 - Nov 20, 03

Technology Profile

Technology Matters
A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 2
A61K: PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 19
C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 7

See more…

Patents / Publication

Patents / Publication #Year of Publication / IssuedTitleCitations
2020/0246,4432020THERAPEUTIC CANCER VACCINE TARGETED TO HAAH (ASPARTYL-[ASPARAGINYL]-BETA-HYDROXYLASE)0
107025912020Therapeutic cancer vaccine targeted to HAAH (aspartyl-[asparaginyl]-beta-hydroxylase0
2018/0092,9692018Therapeutic Cancer Vaccine Targeted to HAAH (Aspartyl-[Asparaginyl]-Beta-Hydroxylase0
97442232017Therapeutic cancer vaccine targeted to HAAH (aspartyl-[asparaginyl]-β-hydroxylase)1
2017/0072,0342017THERAPEUTIC CANCER VACCINE TARGETED TO HAAH (ASPARTYL-[ASPARAGINYL]-BETA-HYDROXYLASE)1

See more…


We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
> Upgrade to our Level for up to -1 portfolios!.